August 22, 2024 Economics - General 0 Comments What are the potential productivity impacts of new medications that treat Medicare beneficiaries? – Healthcare Economist One key aspect of many medications is that they not only help people feel better, but often these medications ... Read More
August 21, 2024 Dynamic cost-effectiveness 0 Comments Impact of genericization on drug prices and treatment value across 8 countries – Healthcare Economist An interesting study from Miquel Serra-Burriel et al. (2024) examines the impact of genericization on drug prices across 8 ... Read More
August 15, 2024 Current Events 0 Comments Medicare Drug Price Negotiation leads to 38% to 79% price decrease – Healthcare Economist Medicare drug price negotiation is here. The maximum fair prices (MFP) set by Medicare lead to discounts between 38% and 79%. In fact, the ... Read More
August 6, 2024 Cancer 0 Comments Should we extrapolate survival using ‘cure’ models? – Healthcare Economist Clinical trials are short, but the benefits of many drugs lasts months or even years beyond the duration of these trials. To quantify the ... Read More
August 2, 2024 Concentration index 0 Comments Health and wealth – Healthcare Economist Are wealthier people healthier? If so, how strong is this relationship? Does it vary across countries? That is what a paper by Kyriopoulos et ... Read More
July 31, 2024 Adverse Event 0 Comments Methods for Including Adverse Events in Economic Evaluations – Healthcare Economist That is the title of a great review paper by Salah Ghabri, Dalia Dawoud and Michael Drummond. They discuss that guidance on the incorporation ... Read More
July 29, 2024 Comepetition 0 Comments Has there been a decline in competition in the US? – Healthcare Economist This is a difficult question to answer. Consider the following world views: Decline-in-competition. Competition has declined because we observe increased market concentration, increased markets, ... Read More
July 24, 2024 Health 0 Comments What outcomes should we target to improve health outcomes and overall well-being? – Healthcare Economist The Rippel Foundation has an interesting framework to describe the dimensions for improving health and overall individual quality of ... Read More
July 19, 2024 Administrative Costs 0 Comments Why doctors don’t like insurance – Healthcare Economist If you go to the doctor or dentist in the US, you often can get a discount if you ... Read More
July 16, 2024 FTC 0 Comments FTC report on PBMs – Healthcare Economist Last week, the Federal Trade Commission (FTC) released a report titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ... Read More